As a pharmaceutical company, our work requires us to cultivate strong relationships with customers, partners, employees and stakeholders – and confidence among the general public. We're working every day to earn that trust. Providing transparent information about our company is part of that endeavor.
Our parent company in the United States communicates proactively and in detail:
in our Financial Reports and Corporate Responsibility Reports
by registering all clinical trials at www.clinicaltrials.gov and publishing the results
through the media
At national level, we publish the support of patient organizations since 2011. Additionally from 2016, we disclose annually our transfers of value to health care professionals and health care organizations.
Due to the dissolution of the joint vaccine portfolio by Sanofi Pasteur MSD (SPMSD) at the end of December 2016, all transfers of value granted by SPMSD to health care professionals and health care organizations are also published here.
2020
MSD Methodology Statement
MSD Report 2020
MSD Self-Certification Letter, issued by Merck & Co., Inc., Kenilworth, NJ, USA
2019
MSD Methodology Statement
MSD Report 2019
MSD Self-Certification Letter, issued by Merck & Co., Inc., Kenilworth, NJ, USA
2018
MSD Methodology Statement
MSD Report 2018
MSD Self-Certification Letter, issued by Merck & Co., Inc., Kenilworth, NJ, USA
CH-NON-00866, 11/2020